SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000899140-24-000506
Filing Date
2024-04-29
Accepted
2024-04-29 16:08:20
Documents
2
Group Members
AARON COWENAVERILL MADISON MASTER FUND, LTD.AVERILL MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D s042924a.htm SC 13D 99797
2 JOINT FILING AGREEMENT s042924b.htm EX-99.1 25893
  Complete submission text file 0000899140-24-000506.txt   127352
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

IRS No.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Subject) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91726 | Film No.: 24890688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)